KPC Pharmaceuticals Inc (600422) - Cash Flow Conversion Efficiency
Based on the latest financial reports, KPC Pharmaceuticals Inc (600422) has a cash flow conversion efficiency ratio of 0.016x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥113.07 Million ≈ $16.55 Million USD) by net assets (CN¥6.94 Billion ≈ $1.02 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is KPC Pharmaceuticals Inc worth for the company's overall valuation and market capitalisation.
KPC Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how KPC Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
KPC Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of KPC Pharmaceuticals Inc ranked by their cash flow conversion efficiency. Explore 600422 operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Centuria Capital Group
AU:CNI
|
0.019x |
|
Mader Group Ltd
AU:MAD
|
0.132x |
|
Jiangsu Jiangnan Water Co Ltd
SHG:601199
|
0.028x |
|
Ningbo Donly Co Ltd
SHE:002164
|
0.025x |
|
Rezolve AI Limited Ordinary Shares
NASDAQ:RZLV
|
-0.229x |
|
Jiangxi Firstar Panel Technology Co Ltd
SHE:300256
|
0.110x |
|
NCC Limited
NSE:NCC
|
-0.167x |
|
Yubico AB
ST:YUBICO
|
0.075x |
Annual Cash Flow Conversion Efficiency for KPC Pharmaceuticals Inc (1999–2025)
The table below shows the annual cash flow conversion efficiency of KPC Pharmaceuticals Inc from 1999 to 2025. View today's stock price for KPC Pharmaceuticals Inc for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥6.94 Billion ≈ $1.02 Billion |
CN¥289.24 Million ≈ $42.32 Million |
0.042x | -65.21% |
| 2024-12-31 | CN¥6.75 Billion ≈ $987.19 Million |
CN¥808.07 Million ≈ $118.25 Million |
0.120x | +26.31% |
| 2023-12-31 | CN¥7.95 Billion ≈ $1.16 Billion |
CN¥754.33 Million ≈ $110.38 Million |
0.095x | +92.08% |
| 2022-12-31 | CN¥5.14 Billion ≈ $752.51 Million |
CN¥253.90 Million ≈ $37.15 Million |
0.049x | -3.07% |
| 2021-12-31 | CN¥4.94 Billion ≈ $722.92 Million |
CN¥251.63 Million ≈ $36.82 Million |
0.051x | -42.81% |
| 2020-12-31 | CN¥4.60 Billion ≈ $673.51 Million |
CN¥409.94 Million ≈ $59.99 Million |
0.089x | -10.12% |
| 2019-12-31 | CN¥4.33 Billion ≈ $634.22 Million |
CN¥429.50 Million ≈ $62.85 Million |
0.099x | +11.14% |
| 2018-12-31 | CN¥3.95 Billion ≈ $577.79 Million |
CN¥352.07 Million ≈ $51.52 Million |
0.089x | +38.74% |
| 2017-12-31 | CN¥3.77 Billion ≈ $552.21 Million |
CN¥242.53 Million ≈ $35.49 Million |
0.064x | -25.39% |
| 2016-12-31 | CN¥3.61 Billion ≈ $528.55 Million |
CN¥311.16 Million ≈ $45.53 Million |
0.086x | -39.71% |
| 2015-12-31 | CN¥3.34 Billion ≈ $488.14 Million |
CN¥476.62 Million ≈ $69.74 Million |
0.143x | -22.76% |
| 2014-12-31 | CN¥2.05 Billion ≈ $299.93 Million |
CN¥379.13 Million ≈ $55.48 Million |
0.185x | +43.65% |
| 2013-12-31 | CN¥1.88 Billion ≈ $274.98 Million |
CN¥241.97 Million ≈ $35.41 Million |
0.129x | -36.22% |
| 2012-12-31 | CN¥1.06 Billion ≈ $154.63 Million |
CN¥213.33 Million ≈ $31.22 Million |
0.202x | +32.09% |
| 2011-12-31 | CN¥917.52 Million ≈ $134.26 Million |
CN¥140.24 Million ≈ $20.52 Million |
0.153x | +38.02% |
| 2010-12-31 | CN¥820.15 Million ≈ $120.01 Million |
CN¥90.82 Million ≈ $13.29 Million |
0.111x | -36.41% |
| 2009-12-31 | CN¥738.35 Million ≈ $108.04 Million |
CN¥128.57 Million ≈ $18.81 Million |
0.174x | +27.48% |
| 2008-12-31 | CN¥670.50 Million ≈ $98.12 Million |
CN¥91.59 Million ≈ $13.40 Million |
0.137x | -33.29% |
| 2007-12-31 | CN¥635.17 Million ≈ $92.94 Million |
CN¥130.06 Million ≈ $19.03 Million |
0.205x | +95.19% |
| 2006-12-31 | CN¥583.86 Million ≈ $85.44 Million |
CN¥61.25 Million ≈ $8.96 Million |
0.105x | +135.35% |
| 2005-12-31 | CN¥588.02 Million ≈ $86.05 Million |
CN¥-174.52 Million ≈ $-25.54 Million |
-0.297x | -7626.53% |
| 2004-12-31 | CN¥723.20 Million ≈ $105.83 Million |
CN¥-2.78 Million ≈ $-406.50K |
-0.004x | -104.14% |
| 2003-12-31 | CN¥659.95 Million ≈ $96.57 Million |
CN¥61.23 Million ≈ $8.96 Million |
0.093x | +204.86% |
| 2002-12-31 | CN¥571.17 Million ≈ $83.58 Million |
CN¥17.38 Million ≈ $2.54 Million |
0.030x | -74.60% |
| 2001-12-31 | CN¥559.74 Million ≈ $81.91 Million |
CN¥67.07 Million ≈ $9.81 Million |
0.120x | +39.91% |
| 2000-12-31 | CN¥557.64 Million ≈ $81.60 Million |
CN¥47.76 Million ≈ $6.99 Million |
0.086x | -79.96% |
| 1999-12-31 | CN¥140.93 Million ≈ $20.62 Million |
CN¥60.24 Million ≈ $8.81 Million |
0.427x | -- |
About KPC Pharmaceuticals Inc
KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, comether tablets, specialty herbal products, classic prescription for bones and joint, ant… Read more